|
1
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohn SL, Pearson AD, London WB, et al: The
International Neuroblastoma Risk Group (INRG) classification
system: an INRG Task Force report. J Clin Oncol. 27:289–297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
4
|
Gonzalez-Sarmiento R and Perez-Losada J:
Breast cancer, a stem cell disease. Curr Stem Cell Res Ther.
3:55–65. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Atlasi Y, Mowla SJ, Ziaee SA and Bahrami
AR: OCT-4, an embryonic stem cell marker, is highly expressed in
bladder cancer. Int J Cancer. 120:1598–1602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ailles LE and Weissman IL: Cancer stem
cells in solid tumors. Curr Opin Biotechnol. 18:460–466. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Komuro H, Saihara R, Shinya M, et al:
Identification of side population cells (stem-like cell population)
in pediatric solid tumor cell lines. J Pediatr Surg. 42:2040–2045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross RA and Spengler BA: Human
neuroblastoma stem cells. Semin Cancer Biol. 17:241–247. 2007.
View Article : Google Scholar
|
|
10
|
Ross RA, Biedler JL and Spengler BA: A
role for distinct cell types in determining malignancy in human
neuroblastoma cell lines and tumors. Cancer Lett. 197:35–39. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ciccarone V, Spengler BA, Meyers MB,
Biedler JL and Ross RA: Phenotypic diversification in human
neuroblastoma cells: expression of distinct neural crest lineages.
Cancer Res. 49:219–225. 1989.PubMed/NCBI
|
|
12
|
Ross RA, Spengler BA, Domenech C, et al:
Human neuroblastoma I-type cells are malignant neural crest stem
cells. Cell Growth Differ. 6:449–456. 1995.PubMed/NCBI
|
|
13
|
Walton JD, Kattan DR, Thomas SK, et al:
Characteristics of stem cells from human neuroblastoma cell lines
and in tumors. Neoplasia. 6:838–845. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sinclair AH, Berta P, Palmer MS, et al: A
gene from the human sex-determining region encodes a protein with
homology to a conserved DNA-binding motif. Nature. 346:240–244.
1990. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamachi Y, Uchikawa M and Kondoh H:
Pairing SOX off: with partners in the regulation of embryonic
development. Trends Genet. 16:182–187. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiang R, Liao D, Cheng T, et al:
Downregulation of transcription factor SOX2 in cancer stem cells
suppresses growth and metastasis of lung cancer. Br J Cancer.
104:1410–1417. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji J and Zheng PS: Expression of Sox2 in
human cervical carcinogenesis. Hum Pathol. 41:1438–1447. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang X, Yu W, Li L, et al: ChIP-seq and
functional analysis of the SOX2 gene in colorectal cancers. OMICS.
14:369–384. 2010. View Article : Google Scholar
|
|
19
|
Gen Y, Yasui K, Zen Y, et al: SOX2
identified as a target gene for the amplification at 3q26 that is
frequently detected in esophageal squamous cell carcinoma. Cancer
Genet Cytogenet. 202:82–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakatsugawa M, Takahashi A, Hirohashi Y,
et al: SOX2 is overexpressed in stem-like cells of human lung
adenocarcinoma and augments the tumorigenicity. Lab Invest.
91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu Y, Futtner C, Rock JR, et al: Evidence
that SOX2 overexpression is oncogenic in the lung. PLoS One.
5:e110222010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang S, Zheng J, Ma Y, et al: Oct4 and
Sox2 are overexpressed in human neuroblastoma and inhibited by
chemotherapy. Oncol Rep. 28:186–192. 2012.PubMed/NCBI
|
|
23
|
Melone MA, Giuliano M, Squillaro T, et al:
Genes involved in regulation of stem cell properties: studies on
their expression in a small cohort of neuroblastoma patients.
Cancer Biol Ther. 8:1300–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui H, Ma J, Ding J, et al: Bmi-1
regulates the differentiation and clonogenic self-renewal of I-type
neuroblastoma cells in a concentration-dependent manner. J Biol
Chem. 281:34696–34704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng J, Xiao X, Liu J, et al:
Growth-promoting effect of environmental endocrine disruptors on
human neuroblastoma SK-N-SH cells. Environ Toxicol Pharmacol.
24:189–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hansford LM, McKee AE, Zhang L, et al:
Neuroblastoma cells isolated from bone marrow metastases contain a
naturally enriched tumor-initiating cell. Cancer Res.
67:11234–11243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tong QS, Zheng LD, Tang ST, et al:
Expression and clinical significance of stem cell marker CD133 in
human neuroblastoma. World J Pediatr. 4:58–62. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jori FP, Galderisi U, Piegari E, et al:
RB2/p130 ectopic gene expression in neuroblastoma stem cells:
evidence of cell-fate restriction and induction of differentiation.
Biochem J. 360:569–577. 2001. View Article : Google Scholar : PubMed/NCBI
|
